Video

Eleven-Year-Old MPN Hero Remains Positive in the Face of Uncertainty

Author(s):

Cannon McMullin was diagnosed with essential thrombocythemia at 8 years old and has remained positive through years of treatment by focusing on the things he likes to do.

Cannon McMullin was diagnosed with essential thrombocythemia (ET) at 8 years old, and now at age 11, has been living with the disease for 3 years. Cannon is the youngest of his siblings but has shown the poise of someone much older than him as he regularly travels for treatments and checkups with his parents, making him an MPN Hero and example for all patients to look too.

While Cannon has had his struggles with the disease the current treatment, he is on has allowed him to live a mostly normal life and continue to pursue the activities he loves, like basketball. Cannon is also a part of a clinical study investigating a new treatment, and Cannon knows that his participation in this trial is vital to the ongoing study of patients with ET, but more importantly, he’s doing it to help patients like him.

In an interview with CURE, Cannon discussed how he remains positive and some of the things he thinks about while undergoing treatment and traveling for meetings with physicians.

TRANSCRIPTION

I just try to think of things that make me happy and just try not to think of the disease that I have. Like, I like sports games or like Call of Duty and fortnight, games like those.

In the summer we live really close to a lake, and so we'll put our kayaks down a little bit down the road then we'll kayak down to the beach and then drive back to our house.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Image of man with text.
Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to advancing kidney cancer care.
Dr. Breelyn Wilky stresses the importance of expert guidance and second opinions for patients with GIST, as treatment options continue to evolve rapidly.
Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns.
Image of woman with text.
Image of goy, and text.
Watch oncology dietitian Kenisha Parikh prepare creamy lentil soup, a soothing, protein-packed recipe to help ease side effects during treatment.
Related Content